Journal list Promote Sponsor
verified SJR 0,741 · Q1 • database Scopus / SJR & Web of Science indexed
Journal of Surgical Oncology
United States · Wiley-Liss Inc.
workspace_premium Q1 — Medicine (miscellaneous) lock_open Open Access

Journal of Surgical Oncology

Journal of Surgical Oncology is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 136. It has a price of 3500 €. It has an SJR impact factor of 0,741 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,741.

Journal of Surgical Oncology focuses its scope in these topics and keywords: patients, cancer, intrahepatic, clinical, carcinoma, vertebral, therapy, protein, colorectal, metastasis, ...

ISSN: 0022-4790
Publisher: Wiley-Liss Inc.
Category: Medicine (miscellaneous)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,741 Q1
H-index 136
Acceptance rate pie_chart
23% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.500 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,741

H-index

136

Docs (year)

557

Docs 3y

1126

Total refs

17962

Cites 3y

2235

Citable 3y

980

Cites/Doc 2y

1.85

Ref/Doc

32.25

Immediate OA

3500 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Clinically aggressive pseudomyxoma peritonei: A variant of a histologically indolent process

View more

Tumor markers and colorectal cancer: Utility in management

View more

Computerized tomogram to design surgery for removal of large Merkel cell carcinoma of the buttock preserving the function of the extremity

View more

Comparisons of outcomes and survivals for two central venous access port systems

View more

Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)

View more

Commentary

View more

Commentary

View more

Commentary

View more

Commentary

View more

Commentary

View more

Combination technique is superior to dye alone in identification of the sentinel node in breast cancer patients

View more

Colon cancer screening: Where have we come from and where do we go?

View more
SHOW MORE ARTICLES

Clinicopathological features of multiple primary gastric carcinoma

View more

Accelerated partial breast irradiation: A change in treatment paradigm for early stage breast cancer

View more

Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma

View more

Clinical research in surgery: The role of the American College of Surgeons Oncology Group

View more

CC chemokine receptor 6 expression predicts poor prognosis in hepatocellular carcinoma

View more

Breast-conserving therapy (BCT) for early-stage breast cancer

View more

Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial

View more

Application of99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma

View more

Application of minimally invasive treatment for early gastric cancer

View more

Advances in flap monitoring and impact of enhanced recovery protocols

View more

Adult perineal sarcomas

View more

Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation bycis-diamminedichloroplatinum(II)

View more

FAQs